Shares of Cardinal Health, Inc. (NYSE:CAH – Get Free Report) have earned a consensus rating of “Moderate Buy” from the fourteen analysts that are presently covering the company, Marketbeat reports. Four equities research analysts have rated the stock with a hold rating and ten have issued a buy rating on the company. The average 1-year price target among brokers that have covered the stock in the last year is $146.43.
CAH has been the subject of a number of recent analyst reports. Jefferies Financial Group upgraded Cardinal Health from a “hold” rating to a “buy” rating and upped their target price for the company from $140.00 to $150.00 in a report on Wednesday, February 5th. Bank of America boosted their price objective on shares of Cardinal Health from $150.00 to $155.00 and gave the company a “buy” rating in a research report on Friday, April 11th. UBS Group upped their price objective on shares of Cardinal Health from $150.00 to $160.00 and gave the stock a “buy” rating in a report on Tuesday, April 29th. Robert W. Baird raised their target price on shares of Cardinal Health from $156.00 to $170.00 and gave the stock an “outperform” rating in a research report on Friday, May 2nd. Finally, Morgan Stanley boosted their price target on shares of Cardinal Health from $142.00 to $166.00 and gave the company an “overweight” rating in a research report on Monday, May 5th.
View Our Latest Research Report on Cardinal Health
Institutional Trading of Cardinal Health
Cardinal Health Stock Up 0.5%
Shares of Cardinal Health stock opened at $155.19 on Tuesday. The company’s fifty day simple moving average is $142.12 and its two-hundred day simple moving average is $130.61. Cardinal Health has a 12-month low of $93.17 and a 12-month high of $156.80. The firm has a market cap of $37.04 billion, a PE ratio of 28.95, a price-to-earnings-growth ratio of 1.49 and a beta of 0.66.
Cardinal Health (NYSE:CAH – Get Free Report) last posted its earnings results on Thursday, May 1st. The company reported $2.35 earnings per share (EPS) for the quarter, topping the consensus estimate of $2.15 by $0.20. The company had revenue of $54.88 billion for the quarter, compared to analysts’ expectations of $55.33 billion. Cardinal Health had a negative return on equity of 59.57% and a net margin of 0.59%. Cardinal Health’s quarterly revenue was up .0% on a year-over-year basis. During the same period last year, the firm earned $2.08 earnings per share. As a group, sell-side analysts expect that Cardinal Health will post 7.95 earnings per share for the current fiscal year.
Cardinal Health Increases Dividend
The firm also recently announced a quarterly dividend, which will be paid on Tuesday, July 15th. Shareholders of record on Tuesday, July 1st will be paid a dividend of $0.5107 per share. This is an increase from Cardinal Health’s previous quarterly dividend of $0.51. The ex-dividend date of this dividend is Tuesday, July 1st. This represents a $2.04 dividend on an annualized basis and a dividend yield of 1.32%. Cardinal Health’s dividend payout ratio (DPR) is currently 31.83%.
Cardinal Health Company Profile
Cardinal Health, Inc operates as a healthcare services and products company in the United States, Canada, Europe, Asia, and internationally. It provides customized solutions for hospitals, healthcare systems, pharmacies, ambulatory surgery centers, clinical laboratories, physician offices, and patients in the home.
Recommended Stories
- Five stocks we like better than Cardinal Health
- Stock Analyst Ratings and Canadian Analyst Ratings
- Ulta’s Beautiful Q1 Earnings Report Points to More Gains Ahead
- How is Compound Interest Calculated?
- Top 3 ETFs Defense Hawks Are Buying
- Trading Stocks: RSI and Why it’s Useful
- Zscaler Will Hit $360 Soon: Here’s the How and Why
Receive News & Ratings for Cardinal Health Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Cardinal Health and related companies with MarketBeat.com's FREE daily email newsletter.